HUGE.CN
Price:
$0.125
Market Cap:
$63.69K
FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD201, a palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. is headquartered in Toronto, Canada.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-05-29
Stock Exchange
CNQ
Ticker
HUGE.CN
According to FSD Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -100.00% compared to the average of -359.42 of the last 4 quarters.
The mean historical PE Ratio of FSD Pharma Inc. over the last ten years is -74062.78. The current -0.01 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), HUGE.CN's PE Ratio was at its highest in in the September 2018 quarter at 4.88K. The PE Ratio was at its lowest in in the March 2017 quarter at -36913822.08.
Average
-74062.78
Median
-98.14
Minimum
-347400.18
Maximum
-37.37
Discovering the peaks and valleys of FSD Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 79.17%
Maximum Annual PE Ratio = -37.37
Minimum Annual Increase = -98.94%
Minimum Annual PE Ratio = -347400.18
Year | PE Ratio | Change |
---|---|---|
2023 | -98.14 | 18.50% |
2022 | -82.82 | 23.70% |
2021 | -66.95 | 79.17% |
2020 | -37.37 | -54.10% |
2019 | -81.42 | -93.83% |
2018 | -1318.73 | -64.09% |
2017 | -3672.41 | -98.94% |
2016 | -347400.18 | 10.71% |
The current PE Ratio of FSD Pharma Inc. (HUGE.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-82.64
5-year avg
-73.34
10-year avg
-74062.78
FSD Pharma Inc.’s PE Ratio is greater than MedMen Enterprises Inc. (-0.42), greater than HEXO Corp. (-0.22), greater than Cronos Group Inc. (-13.40), greater than 1933 Industries Inc. (-0.25), greater than Cannabix Technologies Inc. (-13.15),
Company | PE Ratio | Market cap |
---|---|---|
-0.42 | $27.66M | |
-0.22 | $38.72M | |
-13.40 | $1.07B | |
-0.25 | $2.45M | |
-13.15 | $50.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like FSD Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like FSD Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is FSD Pharma Inc.'s PE Ratio?
How is the PE Ratio calculated for FSD Pharma Inc. (HUGE.CN)?
What is the highest PE Ratio for FSD Pharma Inc. (HUGE.CN)?
What is the 3-year average PE Ratio for FSD Pharma Inc. (HUGE.CN)?
What is the 5-year average PE Ratio for FSD Pharma Inc. (HUGE.CN)?
How does the current PE Ratio for FSD Pharma Inc. (HUGE.CN) compare to its historical average?